Skip to main content

Home/ Cancer/ Group items tagged science treatment cancer

Rss Feed Group items tagged

anonymous

Learn To Identify Prostate Cancer - 1 views

Cancer is one of the most affected diseases across the globe and among the various types of cancers that can affect the human body, prostate cancer is considered to be the most common type of cance...

signs of prostate cancer prostate cancer treatment cancer research scientific research

started by anonymous on 10 Feb 15 no follow-up yet
OAText's open access

Cancer Journal - 0 views

  •  
    Integrative Cancer Science and Therapeutics (ICST) is an open access, peer-reviewed online journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer and related biomedical science. The Journal is concerned with basic, translational and clinical research, across different disciplines and areas, enhancing insight in understanding, prevention, diagnosis and treatment of cancer. The journal also prioritizes clinical trials evaluating new treatments, accompanied by research on pharmacology and molecular alterations or biomarkers that predict response or resistance to treatment.
Matti Narkia

Radioimmunotherapy: Promising treatment for HIV infection and viral cancers - 0 views

  •  
    February 14, 2009 - (BRONX, NY) - Scientists at Albert Einstein College of Medicine of Yeshiva University have piggybacked antibodies onto radioactive payloads to deliver doses of radiation that selectively target and destroy microbial and HIV-infected cells. The experimental treatment - called radioimmunotherapy, or RIT - holds promise for treating various infectious diseases, including HIV and cancers caused by viruses. The research was presented today at the annual meeting of the American Association for the Advancement of Science (AAAS), the world's largest general scientific society and the publishers of the journal Science.
Matti Narkia

Cancer Therapy With Tetrathiomolybdate: Antiangiogenesis by Lowering Body Copper-A Revi... - 0 views

  •  
    Brewer GJ, Merajver SD. Cancer therapy with tetrathiomolybdate: antiangiogenesis by lowering body copper--a review. Integr Cancer Ther. 2002 Dec;1(4):327-37. Review. PMID: 14664727 [PubMed - indexed for MEDLINE]
OAText's open access

Cancer Journal - 0 views

Integrative Cancer Science and Therapeutics (ICST) is an open access, peer-reviewed online journal interested in attracting high-quality original research and reviews that present or highlight sign...

#science #icst #cancerjournal #scienceandtechnology

started by OAText's open access on 09 Mar 16 no follow-up yet
Matti Narkia

In-vitro effects of polyphenols from cocoa and beta-sitosterol on the growth of human p... - 0 views

  •  
    Jourdain C, Tenca G, Deguercy A, Troplin P, Poelman D. In-vitro effects of polyphenols from cocoa and beta-sitosterol on the growth of human prostate cancer and normal cells. Eur J Cancer Prev. 2006 Aug;15(4):353-61. PMID: 16835506 [PubMed - indexed fo
Matti Narkia

The controversial place of vitamin C in cancer treatment - ScienceDirect - Biochemical ... - 0 views

  •  
    The controversial place of vitamin C in cancer treatment. Verrax J, Calderon PB. Biochem Pharmacol. 2008 Dec 15;76(12):1644-52. Epub 2008 Sep 30. Review. PMID: 18938145 doi:10.1016/j.bcp.2008.09.024    
Matti Narkia

Vitamin D: its role in cancer prevention and treatment - Entrez PubMed - 0 views

  •  
    Holick MF. Vitamin D: its role in cancer prevention and treatment. Prog Biophys Mol Biol. 2006 Sep;92(1):49-59. Epub 2006 Mar 10. Review. PMID: 16566961 [PubMed - indexed for MEDLINE]
Matti Narkia

Boron Neutron Capture Therapy in the Treatment of Locally Recurred Head and Neck Cancer... - 0 views

  •  
    Boron Neutron Capture Therapy in the Treatment of Locally Recurred Head and Neck Cancer. Corrected Proof, 7 August 2007 Leena Kankaanranta, Tiina Seppälä, Hanna Koivunoro, Kauko Saarilahti, Timo Atula, Juhani Collan, Eero Salli, Mika Kortesniemi, Jouni
OAText's open access

Cancer journal - 0 views

Most cancers, also called malignancy, is characterized by an abnormal growth of cells. There are more than 100 types of melanoma malignancy, including breast cancers, melanoma, united states, melan...

science journal icst

started by OAText's open access on 28 Apr 16 no follow-up yet
Matti Narkia

Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agent... - 0 views

  •  
    Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents. Pisanti S, Malfitano AM, Grimaldi C, Santoro A, Gazzerro P, Laezza C, Bifulco M. Best Pract Res Clin Endocrinol Metab. 2009 Feb;23(1):117-31. PMID: 19285265 doi:10.1016/j.beem.2009.02.001    
Matti Narkia

Cheap, safe drug kills most cancers - health - 17 January 2007 - New Scientist - 0 views

  •  
    It sounds almost too good to be true: a cheap and simple drug that kills almost all cancers by switching off their "immortality". The drug, dichloroacetate (DCA), has already been used for years to treat rare metabolic disorders and so is known to be
Matti Narkia

Scripps research team solves structure of 'beneficial' virus | Eureka! Science News - 0 views

  •  
    D structure of the virus, known as Seneca Valley Virus-001, reveals that it is unlike any other known member of the Picornaviridae viral family, and confirms its recent designation as a separate genus "Senecavirus." The new study reveals that the virus's outer protein shell looks like a craggy golf ball¬-one with uneven divets and raised spikes-and the RNA strand beneath it is arranged in a round mesh rather like a whiffleball. "It is not at all like other known picornaviruses that we are familiar with, including poliovirus and rhinoviruses, which cause the common cold," says the study's senior author, Associate Professor Vijay S. Reddy, Ph.D., of The Scripps Research Institute. "This crystal structure will now help us understand how Senecavirus works, and how we can take advantage of it." The Senecavirus is a "new" virus, discovered several years ago by Neotropix Inc., a biotech company in Malvern, Pennsylvania. It was at first thought to be a laboratory contaminant, but researchers found it was a pathogen, now believed to originate from cows or pigs. Further investigation found that the virus was harmless to normal human cells, but could infect certain solid tumors, such as small cell lung cancer, the most common form of lung cancer.
Matti Narkia

A new radiation therapy treatment developed for head and neck cancer patients - 0 views

  •  
    Most head-and-neck cancers that recur locally after prior full-dose conventional radiation therapy respond to Boron Neutron Capture Therapy (BNCT). These results were obtained in a Phase I/II study at the Helsinki University Hospital, Finland. The scienti
Tom Scott

Mayo Clinic researchers trying new approaches to treat a rare lung cancer - 0 views

  •  
    Two doctors at the Mayo Clinic are exploring innovative methods to develop better therapies for mesothelioma, a rare lung cancer.
Matti Narkia

A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients. -... - 0 views

  •  
    Flaig TW, Gustafson DL, Su LJ, Zirrolli JA, Crighton F, Harrison GS, Pierson AS, Agarwal R, Glode LM. A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients. Invest New Drugs. 2007 Apr;25(2):139-46. Epub 2006 Nov 1. PMID
Matti Narkia

Curative Brachytherapy for Recurrent/Residual Tongue Cancer - Entrez PubMed - 0 views

  •  
    Ayukawa F, Shibuya H, Yoshimura RI, Watanabe H, Miura M. Curative Brachytherapy for Recurrent/Residual Tongue Cancer. Strahlenther Onkol. 2007 Mar;183(3):133-137. PMID: 17340071 [PubMed - as supplied by publisher]
Matti Narkia

The role of taxanes and targeted therapies in locally advanced head and neck cancer - E... - 0 views

  •  
    Specenier P, Vermorken JB. The role of taxanes and targeted therapies in locally advanced head and neck cancer. Curr Opin Oncol. 2007 May;19(3):195-201. PMID: 17414636 [PubMed - in process]
Matti Narkia

The challenging integration of platinum compounds, taxanes, and molecular-targeted ther... - 0 views

  •  
    Awada A, Ismael G. The challenging integration of platinum compounds, taxanes, and molecular-targeted therapies in the multidisciplinary treatment of squamous cell carcinoma of the head and neck. Curr Opin Oncol. 2007 May;19(3):177-9. PMID: 17414633 [
Matti Narkia

Mechanisms of Berberine (Natural Yellow 18)-Induced Mitochondrial Dysfunction: Interact... - 0 views

  •  
    Mechanisms of berberine (natural yellow 18)-induced mitochondrial dysfunction: interaction with the adenine nucleotide translocator. Pereira CV, Machado NG, Oliveira PJ. Toxicol Sci. 2008 Oct;105(2):408-17. Epub 2008 Jul 3. PMID: 18599498 doi: 10.1124/jpet.107.128017 The data from the present work appear to show that berberine also presents some degree of toxicity to "nontumor" systems, which should be carefully understood. ANT inhibition in nontumor cells by berberine would be responsible for a decrease in energy production and could also result in MPT induction. To the best of our knowledge, no full toxicity assessment exists for berberine in humans, although its use in several commercially available supplements suggests that the compound may present a relatively wide safety interval. In fact, a study with patients with congestive heart failure treated with 1.2 g/day of oral berberine revealed low toxicity and resulted into an average plasma concentration of 0.11 mg/l which would translate into 0.3µM (Zeng and Zeng, 1999Go). Repeated cumulative treatments, alternative forms of formulation (e.g., topical application vs. injection) or more importantly, active mitochondrial accumulation due to its positive charge would be expected to increase its concentration in cells into the range of concentrations used in this study. Empirical data from nontraditional medicines plus the use of extensive clinical assays would allow the use of berberine as a promising antimelanoma agent while maintaining its safety for humans. In radial/vertical forms of melanoma, a possible topical application of berberine would also be possible, thus minimizing side effects on other organs. In conclusion, the present work identifies the ANT as an important target for berberine, with clear relevance for its proposed antitumor effects.
1 - 20 of 22 Next ›
Showing 20 items per page